American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction Report uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Lymph Node Excision
  • Lymph Nodes
  • Sentinel Lymph Node Biopsy

publication date

  • July 2009

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1200/JOP.0948502

Additional Document Info

start page

  • 196

end page

  • 199

volume

  • 5

number

  • 4